Q4 2019

Filed Mar 2, 2020 · 10-K · 62 days after period end · 0001564590-20-008161

Q4 2019 · 10-K

derived · Computed from the longer spans the company filed.

Revenue

$7.97M

derived−92.6% vs Q4 2018

Net Income

-$98.12M

derivedN/M vs Q4 2018

EPS, diluted—

Same quarter

Metric	Q4 2019derived from reported figures	Q4 2018derived from reported figures	Q4 2017derived from reported figures	Q4 2016derived from reported figures
Revenue	$7.97M	$108.05M	$30.74M	$35.53M
Net Income	-$98.12M	$20.95M	-$33.89M	-$30.39M

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Kyntra Bio, Inc. · CIK 921299 · Engraved from SEC EDGAR